NVAX Trade on Apr 21, 2020 11:30 from beno: Tradervue User Stock Trades.

Fundamentals

As of: Sep 30 2019 Q (Share outstanding is latest)
Shares Outstanding (latest from broker): 42.6m
Cash: 71.167m (+$250m from recent offerings)
Current liabilities: 21.575m
Current ratio: 4.2
NWC (total current assets - total current liabilities): 67.5m
Accumulated deficit: 1.4b (WOW THIS IS HUGE)
Book value per share (Stock holder equity / Shares outstanding): -6.08
Monthly Burn rate (net cash used in operating activities / months): 12.54m
Estimated current cash: 258.467m (with cash from offerings)

Catalysts / News / Painting the picture

Sympathy play on China Corona Virus outbreak
Begins animal testing for COVID-19 vaccine
$250m shelf on Dec 31 2019 (All used from below prospectuses)
Jan 21 2020: $100m ATM
Mar 02 2020: $150m ATM
Enough cash for 20 months if counting cash from above offerings
April 08 2020: Identifies COVID-19 Vaccine Candidate, Human Testing To Begin In Mid-May

Technical Analysis

-Intraday pattern: Rug Pull
-Levels: 19, 20, 21, 22, 24, 26

Original Plan / Strategy

First test short of 20.80 by 21 level with whole dollar confluence

Review

Took a starter and covered it quickly because SPY was bouncing from support and we were in lul hours.